Ian Waddell's guest appearances

Ian Waddell

BC Humanists Podcast

The Agenda with Steve Paikin (Video)

The Agenda with Steve Paikin (Audio)

Careers in Discovery 

EACR 2016

Jordan Peterson

Steven Pinker

Phil Jones

Nick Taylor

Tim Newton

Stephanie Smith

Carrie Jenkins

Peter Boghossian

Les Brown

Katie Marshall

Chris Williams

Gail Miller

Matt Higgins

David Cook

David Silverman

OwlTail

"If you're using rational persuasion - as most scientists do by default - and it's not working, and you feel like you're banging your head against a brick wall, it's not the brick wall that's stupid....it's not so much the influencing skills themselves that are important, because they can be learned, but understanding that it's up to you to change your approach when needed." Ian Waddell is the Chief Scientific Officer of Cumulus Oncology, Europe's first oncology drug development accelerator. A prominent figure in drug discovery, Ian joined us to discuss his career, the real advantages and challenges of working in a CRO and why sometimes, even if you're happy, moving on is the right thing to do. Enjoy!

"If you're using rational persuasion - as most scientists do by default - and it's not working, and you feel like you're banging your head against a brick wall, it's not the brick wall that's stupid....it's not so much the influencing skills themselves that are important, because they can be learned, but understanding that it's up to you to change your approach when needed." Ian Waddell is the Chief Scientific Officer of Cumulus Oncology, Europe's first oncology drug development accelerator. A prominent figure in drug discovery, Ian joined us to discuss his career, the real advantages and challenges of working in a CRO and why sometimes, even if you're happy, moving on is the right thing to do. Enjoy!

Ian Waddell, Cumulus Oncology

Ian Waddell is a Canadian politician, author and filmmaker who served in the House of Commons from 1979 to 1993 and in the Legislative Assembly of British Columbia from 1996 to 2001. Currently, Waddell is a documentary film producer and a consultant in environmental and aboriginal affairs. In December 2013 he was appointed the honorary title of Queen’s Counsel for his merit and exceptional contribution to law. His film The Drop: Why Young People Don’t Votewon the Best Producer Award in the Beverly Hills Film Festival. He lives in Vancouver.He spoke to us about his new memoir, Take the Torch. He begins with reference to a recent CPAC interview: https://www.youtube.com/watch?v=X5MrSAWy37kTo learn more about the BC Humanist Association visit https://www.bchumanist.ca

Ian Waddell is a Canadian politician, author and filmmaker who served in the House of Commons from 1979 to 1993 and in the Legislative Assembly of British Columbia from 1996 to 2001. Currently, Waddell is a documentary film producer and a consultant in environmental and aboriginal affairs. In December 2013 he was appointed the honorary title of Queen’s Counsel for his merit and exceptional contribution to law. His film The Drop: Why Young People Don’t Votewon the Best Producer Award in the Beverly Hills Film Festival. He lives in Vancouver. He spoke to us about his new memoir, Take the Torch. He begins with reference to a recent CPAC interview: <a href="https://www.youtube.com/watch?v=X5MrSAWy37k" rel="nofollow" target="_blank">https://www.youtube.com/watch?v=X5MrSAWy37k</a> To learn more about the BC Humanist Association visit <a href="https://www.bchumanist.ca" rel="nofollow" target="_blank">https://www.bchumanist.ca</a>

Ian Waddell - Pass the torch

Published: 14.07.16 Views: 365 Rating:SHARESHORTLISTDr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UKDr Waddell speaks with ecancertv at EACR 2016 about changes in drug discovery.With reference to his own research in PARG inhibitors, targeting therapies is described by Dr Waddell as an essential part of drug design, with biomarkers and patient selection are the forefront in trial design.He also reports on Project Achilles from Dana Farber Cancer Institute.

Published: 14.07.16 Views: 365 Rating: SHARESHORTLIST Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK Dr Waddell speaks with ecancertv at EACR 2016 about changes in drug discovery. With reference to his own research in PARG inhibitors, targeting therapies is described by Dr Waddell as an essential part of drug design, with biomarkers and patient selection are the forefront in trial design. He also reports on Project Achilles from Dana Farber Cancer Institute.

The changing process of drug discovery and design - Dr Ian Waddell